Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Covariate determinants of effective dosing regimens for time-dependent beta-lactam antibiotics for critically ill patients

M. Kaska, E. Havel, I. Selke-Krulichova, P. Safranek, J. Bezouska, J. Martinkova

. 2018 ; 162 (3) : 219-226. [pub] 20180327

Language English Country Czech Republic

Document type Journal Article, Observational Study

Persistent link   https://www.medvik.cz/link/bmc19003014

AIMS: Critically ill patients undergoing aggressive fluid resuscitation and treated empirically with hydrosoluble time-dependent beta-lactam antibiotics are at risk for sub-therapeutic plasma concentrations. The aim of this study was to assess the impact of two covariates - creatinine clearance (Clcr) and cumulative fluid balance (CFB) on pharmacokinetics/pharmacodynamics (PK/PD) target attainment within a week of treatment with meropenem (ME) or piperacillin/tazobactam (PIP/TZB). METHODS: In this prospective observational pharmacokinetic (PK) study, 18 critically ill patients admitted to a surgical Intensive Care Unit (ICU) were enrolled. The primary PK/PD target was free antibiotic concentrations above MIC at 100% of the dosing interval (100%fT>MIC) to obtain maximum bactericidal activity. Drug concentration was measured using liquid chromatography-tandem mass spectrometry. RESULTS: The treatment of both 8 septic patients with IV extended ME dosing 2 g/3 h q8 h and 10 polytraumatized patients with IV intermittent PIP/TZB dosing 4.0/0.5 g q8 h was monitored. 8/18 patients (44%) manifested augmented renal clearence (ARC) where Clcr ≥130 mL/min/1.73 m2. Maximum changes were reported on days 2-3: the median positive CFB followed by the large median volume of distribution: Vdme=70.3 L (41.9-101.5), Vdpip = 46.8 L (39.7-60.0). 100%fTme>MIC was achieved in all patients on ME (aged ≥60 years), and only in two patients (non-ARC, aged ≥65 years) out of 10 on PIP/TZB. A mixed model analysis revealed positive relationship of CFBpip with Vdpip (P=0.021). CONCLUSION: Assuming that the positive correlation between CFB and Vd exists for piperacillin in the setting of the pathological state, then CFB should predict Vdpip across subjects at each and every time point.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19003014
003      
CZ-PrNML
005      
20200121144408.0
007      
ta
008      
190116s2018 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2018.011 $2 doi
035    __
$a (PubMed)29582860
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Kaška, Milan, $u Department of Surgery, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic; Academic Department of Surgery, Faculty of Medicine in Hradec Kralove, Charles University and Department of Surgery, University Hospital, Hradec Kralove, Czech Republic $d 1951- $7 xx0070766
245    10
$a Covariate determinants of effective dosing regimens for time-dependent beta-lactam antibiotics for critically ill patients / $c M. Kaska, E. Havel, I. Selke-Krulichova, P. Safranek, J. Bezouska, J. Martinkova
520    9_
$a AIMS: Critically ill patients undergoing aggressive fluid resuscitation and treated empirically with hydrosoluble time-dependent beta-lactam antibiotics are at risk for sub-therapeutic plasma concentrations. The aim of this study was to assess the impact of two covariates - creatinine clearance (Clcr) and cumulative fluid balance (CFB) on pharmacokinetics/pharmacodynamics (PK/PD) target attainment within a week of treatment with meropenem (ME) or piperacillin/tazobactam (PIP/TZB). METHODS: In this prospective observational pharmacokinetic (PK) study, 18 critically ill patients admitted to a surgical Intensive Care Unit (ICU) were enrolled. The primary PK/PD target was free antibiotic concentrations above MIC at 100% of the dosing interval (100%fT>MIC) to obtain maximum bactericidal activity. Drug concentration was measured using liquid chromatography-tandem mass spectrometry. RESULTS: The treatment of both 8 septic patients with IV extended ME dosing 2 g/3 h q8 h and 10 polytraumatized patients with IV intermittent PIP/TZB dosing 4.0/0.5 g q8 h was monitored. 8/18 patients (44%) manifested augmented renal clearence (ARC) where Clcr ≥130 mL/min/1.73 m2. Maximum changes were reported on days 2-3: the median positive CFB followed by the large median volume of distribution: Vdme=70.3 L (41.9-101.5), Vdpip = 46.8 L (39.7-60.0). 100%fTme>MIC was achieved in all patients on ME (aged ≥60 years), and only in two patients (non-ARC, aged ≥65 years) out of 10 on PIP/TZB. A mixed model analysis revealed positive relationship of CFBpip with Vdpip (P=0.021). CONCLUSION: Assuming that the positive correlation between CFB and Vd exists for piperacillin in the setting of the pathological state, then CFB should predict Vdpip across subjects at each and every time point.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a antibakteriální látky $x aplikace a dávkování $x farmakokinetika $x farmakologie $7 D000900
650    _2
$a kritický stav $x terapie $7 D016638
650    _2
$a rozvrh dávkování léků $7 D004334
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a meropenem $x aplikace a dávkování $x farmakokinetika $x farmakologie $7 D000077731
650    _2
$a lidé středního věku $7 D008875
650    _2
$a polytrauma $x komplikace $x farmakoterapie $7 D009104
650    _2
$a peritonitida $x komplikace $x farmakoterapie $7 D010538
650    _2
$a piperacilin $x aplikace a dávkování $x farmakokinetika $x farmakologie $7 D010878
650    _2
$a prospektivní studie $7 D011446
650    _2
$a sepse $x farmakoterapie $7 D018805
650    _2
$a septický šok $x farmakoterapie $7 D012772
650    _2
$a syndrom systémové zánětlivé reakce $x farmakoterapie $7 D018746
650    _2
$a výsledek terapie $7 D016896
650    _2
$a mladý dospělý $7 D055815
650    _2
$a beta-laktamy $x aplikace a dávkování $x farmakokinetika $x farmakologie $7 D047090
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Havel, Eduard, $u Department of Surgery, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic; Academic Department of Surgery, Faculty of Medicine in Hradec Kralove, Charles University and Department of Surgery, University Hospital, Hradec Kralove, Czech Republic $d 1962- $7 xx0065539
700    1_
$a Selke Krulichová, Iva, $u Academic Department of Surgery, Faculty of Medicine in Hradec Kralove, Charles University and Department of Surgery, University Hospital, Hradec Kralove, Czech Republic $d 1970- $7 xx0076216
700    1_
$a Šafránek, Petr $u Department of Surgery, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic $7 xx0209339
700    1_
$a Bezouska, Jan $u Academic Department of Surgery, Faculty of Medicine in Hradec Kralove, Charles University and Department of Surgery, University Hospital, Hradec Kralove, Czech Republic
700    1_
$a Martínková, Jiřina, $u Department of Surgery, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic $d 1940- $7 nlk19990073537
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 162, č. 3 (2018), s. 219-226
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29582860 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20190116 $b ABA008
991    __
$a 20200121144745 $b ABA008
999    __
$a ok $b bmc $g 1373965 $s 1041176
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 162 $c 3 $d 219-226 $e 20180327 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20190116
Back

Find record

Citation metrics

Logged in users only

Archiving options